Sunshine Biopharma Inc.: Form 8-K, filed Feb 16, 2024
Filed with the SEC on Feb 16, 2024 and accepted by EDGAR at Feb 16, 2024, 17:01 ET.
Items reported
- Item 5.07 Shareholder vote results
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001683168-24-001049. Last ingested by Listed: Nov 11, 2026, 03:50 ET. Listed shows no prices and gives no investment advice.